75883-46-4 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-[5-(benzoylamino)-4,7-dimethoxy-1-benzofuran-6-yl]oxyethyl)piperidinium chloride is used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique chemical structure may allow it to interact with specific biological targets, potentially leading to the creation of novel therapeutics.
Used in Chemical Industry:
In the chemical industry, 1-(2-[5-(benzoylamino)-4,7-dimethoxy-1-benzofuran-6-yl]oxyethyl)piperidinium chloride may be utilized as a building block or intermediate in the synthesis of other complex organic compounds. Its versatile structure could be valuable in the development of new materials or chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 75883-46-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,8,8 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 75883-46:
(7*7)+(6*5)+(5*8)+(4*8)+(3*3)+(2*4)+(1*6)=174
174 % 10 = 4
So 75883-46-4 is a valid CAS Registry Number.
75883-46-4Relevant academic research and scientific papers
Synthesis and Antiarrhythmic Activity of New Benzofuran Derivatives
Bourgery, Guy,Dostert, Philippe,Lacour, Alain,Langlois, Michel,Pourrias, Bernard,Tisne-Versailles, Jacky
, p. 159 - 167 (2007/10/02)
Various 5-aminobenzofuran derivatives were prepared from khellin and screened intravenously in the dog for their potential antiarrhythmic activity against ouabain-induced ventricular arrhythmia and in the Harris test.From systematic structural variations it was found that two methoxy groups in positions 4 and 7 on the benzofuran ring, a tertiary aminoethoxy side chain in position 6, and a N-methylurea group in position 5 led to the most active compounds.These were then tested orally in the Harris test in the dog.The two long-acting derivativesN--N'-methylurea (8j) and N--N'-methylurea (8m) showed advantages when compared to quinidine and diisopyramide and have been selected for further studies.
